Sweden - Hospital Average Length of Stay for Malignant Neoplasm of Prostate
Since 2014, Sweden Hospital Average Length of Stay for Malignant Neoplasm of Prostate was down by 2.5% year on year. In 2019, the country was number 27 comparing other countries in Hospital Average Length of Stay for Malignant Neoplasm of Prostate at 4.4 Days. Sweden is overtaken by Canada, which was ranked number 26 with 4.5 Days and is followed by Norway with 4 Days. South Korea lead the ranking with 15.9 Days in 2019, that is stable versus 2018. New Zealand, Lithuania and Slovakia respectively ranked number 2, 3 and 4 in this ranking. New Zealand recorded the best 5 years average growth at +2.2% per year, while Mexico witnessed the worst performance at -8.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 4.40 |
| 2018 | 4.40 |
| 2017 | 4.60 |
| 2016 | 4.80 |
| 2015 | 4.60 |
Download all data from 2000 to 2019
How does Sweden rank in Hospital Average Length of Stay for Malignant Neoplasm of Prostate?
| # | 32 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
15.90 | 2019 | +0.0 % | -0.9 % | View data | |
| 2 |
#2
New Zealand
|
11.60 | 2019 | -0.8 % | +2.2 % | View data | |
| 26 |
#26
Canada
|
4.50 | 2019 | -4.3 % | -2.5 % | View data | |
| 27 |
#27
Sweden
|
4.40 | 2019 | +0.0 % | -2.5 % | View data | |
| 28 |
#28
Norway
|
4.00 | 2019 | +5.3 % | -0.5 % | View data | |